106 results
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
20 May 24
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Friedreich’s Ataxia
4:08pm
may not ultimately agree with Larimar’s nomabofusp development strategy; the potential impact of public health crises on Larimar’s future clinical
8-K
EX-99.2
LRMR
Larimar Therapeutics Inc
20 May 24
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Friedreich’s Ataxia
4:08pm
; that the FDA may not ultimately agree with Larimar’s nomlabofusp development strategy; the potential impact of public health crises on Larimar’s future
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
9 May 24
Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
7:02am
clinical trials, and assessments; that the FDA may not ultimately agree with Larimar’s nomlabofusp development strategy; the potential impact of public
8-K
EX-99.2
LRMR
Larimar Therapeutics Inc
9 May 24
Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
7:02am
, and assessments; that the FDA may not ultimately agree with Larimar’s nomlabofusp development strategy; the potential impact of public health crises on Larimar’s
PRE 14A
0ewmtu
12 Apr 24
Preliminary proxy
6:06am
8-K
EX-99.1
usz3s
14 Mar 24
Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development
4:06pm
8-K
EX-99.2
mohpo
11 Mar 24
Other Events
4:09pm
8-K
EX-99.3
qk9lavza5fqh upbk
11 Mar 24
Other Events
4:09pm
8-K
EX-99.1
mf0u33nz
11 Mar 24
Other Events
4:09pm
424B5
7sdmj5
14 Feb 24
Prospectus supplement for primary offering
5:08pm
424B5
i5g69kd 9rdq2u7de
13 Feb 24
Prospectus supplement for primary offering
4:46pm
8-K
EX-99.1
3f5eyoi6in04 8790
12 Feb 24
Results of Operations and Financial Condition
7:03am
8-K
EX-99.3
mlimn1b60hr19yktfdj
12 Feb 24
Results of Operations and Financial Condition
7:03am
8-K
EX-99.2
x5s6tu
12 Feb 24
Results of Operations and Financial Condition
7:03am
8-K
EX-99.1
sxb 94dcuq
14 Nov 23
Larimar Therapeutics Reports Third Quarter 2023 Operating and Financial Results
12:00am